GSK har annonceret dette på clinical trials:

Phase II Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)
This study is not yet open for participant recruitment.
Verified January 2012 by GlaxoSmithKline
First Received on January 19, 2012. Last Updated on January 26, 2012